The Science Committee evaluates new scientific evidence about asthma care, and prepares updates to scientific reports on asthma management and prevention.

Helen K. Reddel, MBBS, PhD, Chair
Macquarie University and University of Sydney
Sydney, NSW, Australia
Sydney Local Health District
Sydney, NSW, Australia

Len Bacharier, MD
Professor of Pediatrics, Vanderbilt University Medical Center
Nashville, Tennessee, USA
Monroe Carell Jr Children's Hospital
Nashville, Tennessee, USA

Matteo Bonini MD, PhD
Department of Public Health and Infectious Diseases, Università Sapienza
Rome, Italy
National Heart and Lung Institute (NHLI), Imperial College
London, United Kingdom

Pr Arnaud Bourdin
University of Montpellier
Department of Respiratory Diseases
Montpellier, France

Chris Brightling MD
University of Leicester
Leicester, United Kingdom

Guy Brusselle, MD, PhD, FERS
Ghent University
Ghent, Belgium
Ghent University Hospital
Ghent, Belgium

Dr. Roland Buhl
Johannes Gutenberg University
Mainz, Germany
Senior Professor, Pulmonary Department
Johannes Gutenberg University Mainz, Germany

Dr Francine Ducharme
University of Montreal
Montreal, Canada
Centre Hospitalier Universitaire Sainte-Justine
Montreal, Canada

Liesbeth Duijts MD, PhD
Erasmus MC, University Medical Center
Rotterdam, The Netherlands

Louise Fleming, MD
Imperial College
London, United Kingdom
Imperial Healthcare NHS Trust and Royal Brompton Hospital
London, United Kingdom

Hiromasa Inoue, MD
Kagoshima University
Kagoshima, Japan
Kagoshima University Hospital
Kagoshima, Japan

Alan Kaplan, MD
University of Toronto
Toronto, Ontario, Canada
Family Physician Airways Group of Canada
Markham, Ontario, Canada

Refiloe Masekela MBBCh, PhD
University of KwaZulu Natal
Durban, KwaZuluNatal
Inkosi Albert Luthuli Central Hospital
Durban, South Africa

Paulo Pitrez, M.D., Ph.D.
Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA)
Porto Alegre, Brasil
Hospital Santa Casa de Porto Alegre
Porto Alegre, Brasil

Dr Sundeep Salvi MD, PhD, Hon FRCP(Lon)
Director Pulmocare Research and Education (PURE) Foundation
Pune, India

Dr Fanny Wai-san Ko
The Chinese University of Hong Kong
Hong Kong, China
Prince of Wales Hospital
Hong Kong, China

Min Zhang
Shanghai Jiao Tong University School of Medicine
Shanghai, China
Department of Respiratory & Critical Care Medicine, Shanghai General Hospital
Shanghai, China
Updated January 2026
GINA Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:
- Personal Benefits (Consultancy-Lecture Fees) refers to fees for lectures, advisory committees or consultancy services either intermittent or regular, from which a GINA member benefits personally. This includes ongoing attendance at advisory board meetings but would not normally include a situation where an individual is paid for a specific item or for attending or speaking at an occasional meeting.
- Shares refers to any shares in the pharmaceutical industry, excluding unit trusts, pension plans or mutual funds, and it refers to shares held by a GINA member or family members (spouse/children). The company is to be listed, not the number of shares.
- Non-Personal Interests refers to fees or grants paid to a GINA Committee member (or the Department/Institution on behalf of a GINA member) and used for research, education, equipment, salaries, etc.
